Delivery Order SPE2DB25D7067-SPE2DB25FSVMF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count) with a ceiling value of $3,170.48. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,584.51 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on April 24, 2025, with completion scheduled for April 25, 2025. This non-set-aside contract represents a firm fixed price delivery order executed under competitive procurement procedures. The award leverages AmerisourceBergen's extensive pharmaceutical distribution capabilities and established relationship with the Defense...
- The Defense Logistics Agency awarded a $1,049.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count) with a completion date of September 9, 2025. This competitive award, with no set-aside designation, is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.40 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,239.43 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,071.28 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,326.72 to AmerisourceBergen Drug Corp for the supply of Estrogen-Methyltestosterone tablets (100 count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,317.41 to AmerisourceBergen Drug Corp for Estrogen-Methyltestosterone tablets (100-count) with a firm fixed price structure. This non-set-aside contract was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,940.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for estrogen-methyltestosterone tablets (100-count) on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside contract was competitively awarded to the major pharmaceutical distributor and reflects routine medical supply procurement for military healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,017 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 4561947349 Estrogen-Methyltestos F.S. tablets. The firm fixed price contract calls for the delivery of 100 tablets to a facility in Conshohocken, Pennsylvania, with performance required between August 25-28, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order for estrogen and testosterone supplements in...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVMFDelivery Order
The Defense Logistics Agency awarded a $1,161.18 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Estrogen-Methyltestosterone tablets (100 count). This firm fixed price contract, with an ultimate completion date of August 7, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is representative of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense Logistics Agency, which encompasses a $999.99 billion prime indefinite delivery vehicle (SPE2DX) extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling supply of a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability to fulfill federal medical procurement requirements and serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/6/25 |